American Diabetes Association Faces Renewed Scrutiny Amid Allegations of "Premeditated Ambush" and Suppressed Scientific Discourse

The American Diabetes Association (ADA) is once again embroiled in controversy as deputy editors of its flagship journal, Diabetes Care, have taken the extraordinary step of publishing an editorial and seven accompanying opinion articles on a preprint server, Zenodo, after the organization allegedly refused to publish them. These new documents not only shed further light on a troubling incident last month where five prominent scientists were ejected from the ADA’s annual meeting in New Orleans for distributing an editorial critical of the Trump administration’s approach to science but also introduce explosive new allegations, including claims that ADA leadership orchestrated a "premeditated ambush" against its own members. The ongoing dispute has ignited a fierce debate within the scientific community regarding academic freedom, organizational governance, and the role of professional societies in public policy advocacy.

The Unfolding Crisis: A Chronology of Events

The current crisis, described by some as an "existential threat" to the ADA, traces its roots back to previous tensions and escalating concerns among the scientific community regarding the political climate’s impact on research and public health.

• The Precedent: A "Broken Health Care System" Session (2025)
  The initial friction within the ADA appears to have begun in 2025, a year prior to the New Orleans incident. Deputy editors Elizabeth Selvin and Cheryl A.M. Anderson organized a 90-minute session titled "How Do We Fix a Broken Health Care System?" for the ADA’s annual meeting. Among the invited panelists was Washington state congresswoman Kim Schrier, a pediatrician living with Type 1 diabetes. According to Selvin and Anderson’s account in the newly released preprint, ADA leadership objected to the session’s "unbalanced" nature months in advance, requesting the inclusion of "a congressperson from across the aisle" and other speakers offering "opposing views." When this proved impractical, the ADA reluctantly approved the original session but notably chose not to advertise it. Selvin and Anderson maintained that the session was non-partisan, with Rep. Schrier focusing on congressional testimonies, her personal experiences with Type 1 diabetes, bipartisan efforts to reduce drug costs, her involvement with the Congressional Diabetes Caucus, and a warning about the potential harm of proposed NIH funding cuts on diabetes research. This initial pushback from leadership signaled an underlying tension regarding the discussion of politically sensitive topics within the organization.

• The April Editorial and the New Orleans Incident (April-June 2026)
  The direct catalyst for the New Orleans debacle was an editorial titled "Misguided Brushes of a Pen Continue to Dismantle" published in Diabetes Care, an ADA journal, in April 2026. This editorial, co-authored by Steven Kahn, the editor-in-chief of Diabetes Care, and other prominent scientists, sharply criticized the Trump administration’s perceived "attacks on scientific research." These attacks encompassed a range of concerns, including proposed budget cuts to federal science agencies like the National Institutes of Health (NIH), a perceived devaluation of scientific expertise in policy-making, and rhetoric that undermined evidence-based decision-making. Such policies were seen by many in the scientific community as directly threatening public health initiatives, including those targeting diabetes research and patient care.

  Fast forward to June 5, 2026, at the ADA’s annual meeting in New Orleans. Five leading scientists – Steven Kahn, Desmond Schatz (a former ADA President), Aaron Kelly, Justin Ryder, Irl Hirsch, and Maureen Gannon – decided to distribute reprints of this April editorial outside the conference’s opening speech. The keynote was originally slated to be delivered by Jay Bhattacharya, who served as head of the National Institutes of Health under the Trump administration, but he canceled at the last minute, with senior NIH official Rick Woychik taking his place. Within minutes of the scientists beginning to hand out the articles, a swift and forceful intervention occurred. Police reportedly escorted the scientists out of the conference, with at least one individual allegedly shoved. All conference badges were confiscated, and threats of arrest were issued if they attempted to return. The Louisiana State Police later confirmed to media outlets that their actions were taken at the specific request of the ADA, which subsequently barred all five scientists from the remainder of the conference.

• Immediate Fallout and Widespread Condemnation
  The incident immediately sparked outrage across the scientific and medical communities. The backlash proliferated rapidly on social media platforms like Twitter/X and BlueSky, dramatically increasing the page views for the April editorial. Several ADA leaders, including Mark Atkinson, chair of the Scientific Sessions Meeting Planning Committee, resigned in protest. A fiery letter, reportedly signed by over 40 ADA officials, condemned the decision as "outrageous," dismissing the organization’s justifications as "unpersuasive" and "fatuous nonsense." This letter articulated the community’s sentiment of being "overwhelmingly repulsed by the way this unfortunate event has occurred and been excused and justified by the Association leadership," demanding an "immediate and unconditional public apology" and a comprehensive review of the incident. Concurrently, an open letter to the ADA, ominously titled "Shame on You," garnered over 7,500 signatures, echoing calls for an apology and accountability.

• The ADA’s Evolving Justifications and Subsequent Apology
  In the immediate aftermath, the ADA initially attempted to justify its actions with a series of evolving explanations. A media team first informed MedPage Today that the scientists had violated the conference code of conduct by distributing unauthorized materials. Subsequently, in an email to ADA members, the association reiterated that the removal was due to a lack of prior approval for material distribution, asserting that it was "not because of the viewpoints expressed in those materials."

  Days later, the organization, a 501(c)(3) nonprofit, shifted its justification, citing federal regulations for nonprofits that require "maintaining a strictly nonpartisan environment at all organizational events and functions while engaging across party affiliations to advance our mission." However, this justification was met with skepticism and legal rebuttal. Federal regulations governing 501(c)(3) organizations primarily restrict direct political campaign intervention (e.g., endorsing candidates or making campaign contributions) and lobbying activities beyond certain limits. They do not restrict leaders or members of organizations from sharing political views in a personal capacity or from speaking out on important public policy issues that directly impact their mission, such as scientific funding or health policy, even if those issues become politicized. This misinterpretation or misapplication of IRS guidelines further fueled the controversy.

  Facing mounting pressure, negative media coverage, and internal dissent, ADA CEO Charles Henderson released a video statement several days later, issuing an apology for the organization’s decision. Henderson stated, "What transpired is not reflective of who I am, the values I hold, or the way I was raised," and pledged to "work hard to bring our community back together." He also promised to commission a "thorough independent review of the events that occurred as well as the policies, procedures, and decision-making process that guided our actions."

  

New Revelations from the Preprint Articles

One month after Henderson’s apology, the five ousted scientists, along with the deputy editors of Diabetes Care, contend that little tangible progress has been made. In their new articles, published on Zenodo, they detail a lack of follow-up meetings with ADA leadership, no official apology beyond Henderson’s video, and no exoneration. Crucially, they point to a complete absence of corrective actions, no resignations of involved ADA staff, and no identification of the individual(s) responsible for the decision to forcibly remove the scientists.

• Allegations of a "Premeditated Ambush"
  Perhaps the most alarming allegation comes from John Buse of the University of North Carolina School of Medicine, who penned one of the opinion pieces. Buse now states his belief that "the ADA actions were a premeditated attack on Steven Kahn and other attendees." The New Orleans Five corroborate this, claiming that ADA leadership was fully aware of their intent to distribute the editorial. Desmond Schatz reportedly texted Chief Scientific and Medical Officer Rita Kalyani before the meeting, advising her to contact Kahn to clarify where materials could be distributed, emphasizing that the activity "should not in any way be disruptive." Kalyani responded that she was on a plane and would address it upon landing, but according to the scientists, she never followed up.

  This alleged foreknowledge, coupled with observations during the ejection, paints a grim picture. As Kahn, Kelly, Ryder, and Schatz were being removed, a police officer reportedly asked the head of conference security if "that was sufficient." The security officer then requested "one more badge," directing them to remove Maureen Gannon, who was part of a group distributing flyers (which had by then been confiscated). When Gannon sought clarification from ADA leadership, the head of security reportedly stated this was precisely what "the client" (i.e., ADA) had instructed them to do.

  Buse starkly concludes, "It was an ambush. ADA leadership knew exactly what was going to happen and when. They could have contacted Steven and tried to come to some accommodation. Instead they set in place armed law enforcement officers to disrupt the activity, apparently with a quota for the number of people to be hustled out of the meeting." He draws a disturbing parallel, noting that "The ADA actions are not dissimilar in nature to the efforts of our federal government to quell protests—force against people exercising constitutional rights as an act of both retribution and a display of power. We are lucky this event did not have even greater consequences."

• Editorial Freedom Under Threat: The Deputy Editors’ Account
  Deputy editors Elizabeth Selvin and Cheryl A.M. Anderson directly accuse the ADA of refusing to publish their editorial and seven accompanying articles. They state, "We are speaking out because it is unusual and unacceptable for a medical society to work at cross purposes with its members and its editors." They highlight previous attempts by the ADA to restrict editorial freedom concerning raising awareness about federal actions impacting the NIH. They emphasize the need to "heal and come together" and believe that for this to happen, "it is important that these articles be read and these voices heard."

  Selvin and Anderson also revealed that in the wake of the June 5 ousters, ADA leadership canceled the scheduled annual in-person meetings with the Diabetes Care editorial board and associate editors, describing it as "the only opportunity we have all year to connect face-to-face with the full editorial team." They further note the irony that the ADA, now "with a public relations crisis firm in tow," has begun emailing advocacy messages opposing federal policies and taking strong stances against proposed changes harmful to diabetes patients and research—"the very things we have been writing about in the journal."

• Resignations and Lack of Accountability
  Mark Atkinson, who resigned as chair of the Scientific Sessions Meeting Planning Committee, detailed his reasons in an opinion piece. He was among the signatories of the initial June 6 ADA letter but claims he never agreed to the final text that was sent out. Atkinson recounted advocating for an apology, not just a defense, during face-to-face discussions. He had to leave the meeting early, expecting to review any final version. Instead, "a substantially different letter was released, bearing my name and that of the ADA’s chief executive officer," he wrote, adding, "Had I been given the opportunity, I would not have agreed to have my name associated with it." His resignation, he stated, was "among the most difficult professional decisions I have ever made," born from a loss of confidence in the organization’s processes.

  The scientists’ collective article also explicitly calls for the promised thorough investigation, the establishment of a formal process to address professional membership concerns, and greater transparency and visibility in the ADA’s patient advocacy and research funding efforts. They demand that the ADA stand behind its journal editors and their publication decisions, insisting that "Any disclaimers need to be removed from the published editorials."

Broader Context: The Role of 501(c)(3) Nonprofits and Scientific Advocacy

This controversy brings into sharp focus the delicate balance that 501(c)(3) nonprofit organizations, particularly scientific and medical societies, must maintain. While they are legally prohibited from engaging in partisan political campaign activities, their mission often necessitates advocating for public policies that support scientific research, public health, and patient well-being. These policy issues, such as government funding for NIH, access to healthcare, or drug pricing, frequently intersect with political debates.

The ADA’s initial justification citing 501(c)(3) regulations highlights a common misconception or, in this case, a potential misapplication of these rules. The IRS guidelines primarily aim to prevent tax-exempt organizations from becoming conduits for political campaigns or from engaging in substantial lobbying that deviates from their charitable purpose. However, they do not generally restrict scholarly discourse, even if it touches on politically charged topics, nor do they prevent individual members or leaders from expressing personal views. In fact, many scientific organizations view it as their duty to speak truth to power and advocate for evidence-based policies, particularly when scientific integrity or public health is perceived to be under threat. Suppressing such discourse within its own publications, especially when it emanates from its editorial board, raises profound questions about the ADA’s commitment to its scientific mission and the principles of open inquiry.

Implications for Scientific Societies and Free Discourse

The ADA controversy sends chilling signals throughout the broader scientific community. Professional societies are expected to be bastions of scientific freedom, fostering open debate and the dissemination of evidence-based knowledge. When such organizations are perceived to suppress critical discourse, especially from their own journal editors and prominent members, it can severely erode trust, diminish credibility, and discourage future engagement.

The use of a preprint server to circumvent an alleged publication blockade underscores the evolving landscape of scientific communication. While preprint servers like Zenodo provide rapid dissemination and open access, their necessity in this context highlights a breakdown in traditional publishing processes within a major medical society. It raises questions about the editorial independence of journals affiliated with professional organizations and the extent to which organizational leadership can exert control over scholarly content, particularly when it touches on sensitive political issues.

This incident also serves as a stark reminder of the challenges faced by scientists and advocates in an increasingly polarized political environment. The pressure on organizations to remain "non-partisan" can sometimes be interpreted in ways that stifle legitimate scientific advocacy, especially when policy decisions have direct implications for research funding, public health, and patient care.

The Path Forward: Calls for Reform and Transparency

The path to healing and restoring trust for the American Diabetes Association appears fraught with challenges. The demands from the scientific community are clear: a truly independent and transparent investigation into the events of June 5th, accountability for those responsible, a clear reaffirmation of editorial independence for Diabetes Care and other ADA journals, and a re-evaluation of the organization’s policies regarding scientific advocacy and member engagement. The New Orleans Five specifically called for the removal of any disclaimers from published editorials that suggest a lack of organizational endorsement for scientific opinions that might touch upon policy.

Many believe that the ADA must not only apologize genuinely and unequivocally but also implement structural changes to its governance and communication processes to prevent similar incidents. This could involve clearer guidelines for advocacy, enhanced protections for editorial independence, and robust mechanisms for members to raise concerns without fear of reprisal. John Buse, despite his indignation, ended his editorial on a note of hope, suggesting that an "awakening of the spirit of the science and medicine community" could lead the ADA to "emerge stronger" through a "reworking of governance and engagement to align strategy with mission."

The continuing saga at the American Diabetes Association is more than just an internal organizational dispute; it is a critical test case for scientific freedom, the independence of academic publishing, and the ethical responsibilities of professional societies in an era where scientific integrity is frequently challenged. The eyes of the global scientific community remain fixed on the ADA, awaiting decisive action that can either restore its reputation as a champion of science and health or further entrench doubts about its commitment to open discourse.